Alison Elder
Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Inhalation Exposure | 9 | 2004 | 22 |
Why?
|
Carbon | 7 | 2000 | 30 |
Why?
|
Air Pollutants | 6 | 2000 | 42 |
Why?
|
Oxides | 2 | 2006 | 21 |
Why?
|
Aging | 4 | 2000 | 275 |
Why?
|
Lipopolysaccharides | 6 | 2000 | 98 |
Why?
|
Macrophages, Alveolar | 4 | 2004 | 44 |
Why?
|
Lung | 11 | 2000 | 232 |
Why?
|
Rats, Inbred F344 | 14 | 2000 | 80 |
Why?
|
Vehicle Emissions | 2 | 2004 | 14 |
Why?
|
Clodronic Acid | 2 | 2004 | 12 |
Why?
|
Pneumonia | 3 | 2004 | 85 |
Why?
|
Bronchoalveolar Lavage Fluid | 10 | 2000 | 68 |
Why?
|
Metal Nanoparticles | 2 | 2009 | 10 |
Why?
|
Administration, Inhalation | 9 | 2000 | 60 |
Why?
|
Rats | 17 | 2000 | 530 |
Why?
|
Metals | 2 | 2000 | 35 |
Why?
|
Particle Size | 10 | 2000 | 55 |
Why?
|
Intestinal Mucosa | 1 | 2009 | 56 |
Why?
|
Epidermis | 1 | 2009 | 30 |
Why?
|
Inflammation | 5 | 2000 | 208 |
Why?
|
Respiratory Mucosa | 1 | 2009 | 39 |
Why?
|
Gases | 2 | 2004 | 23 |
Why?
|
Manganese Compounds | 1 | 2006 | 8 |
Why?
|
Autonomic Nervous System | 1 | 2007 | 41 |
Why?
|
Aerosols | 6 | 2002 | 39 |
Why?
|
Foreign-Body Migration | 1 | 2006 | 20 |
Why?
|
Respiratory Tract Diseases | 1 | 2006 | 34 |
Why?
|
Antimetabolites | 1 | 2005 | 21 |
Why?
|
Respiratory System | 1 | 2006 | 30 |
Why?
|
Air Pollution | 1 | 2006 | 17 |
Why?
|
Particulate Matter | 1 | 2006 | 22 |
Why?
|
Central Nervous System | 1 | 2006 | 77 |
Why?
|
Nanoparticles | 3 | 2006 | 13 |
Why?
|
Animals | 19 | 2000 | 1031 |
Why?
|
Blood Pressure | 1 | 2007 | 205 |
Why?
|
Neutrophils | 5 | 2000 | 114 |
Why?
|
Hypertension | 1 | 2007 | 161 |
Why?
|
Titanium | 3 | 2000 | 36 |
Why?
|
Toxicity Tests | 3 | 2004 | 17 |
Why?
|
Polytetrafluoroethylene | 1 | 2000 | 23 |
Why?
|
Endotoxins | 1 | 2000 | 35 |
Why?
|
Immune Tolerance | 1 | 2000 | 72 |
Why?
|
Ozone | 1 | 2000 | 18 |
Why?
|
Reactive Oxygen Species | 4 | 2000 | 112 |
Why?
|
Lung Diseases | 1 | 2000 | 112 |
Why?
|
Pseudomonas aeruginosa | 1 | 2000 | 33 |
Why?
|
Specific Pathogen-Free Organisms | 3 | 2000 | 26 |
Why?
|
Male | 13 | 2000 | 1553 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2000 | 431 |
Why?
|
Age Factors | 3 | 2000 | 480 |
Why?
|
Cytokines | 3 | 2000 | 207 |
Why?
|
Rats, Inbred SHR | 2 | 2004 | 24 |
Why?
|
Injections, Intraperitoneal | 2 | 2004 | 57 |
Why?
|
Automobile Driving | 2 | 2004 | 19 |
Why?
|
Brain | 3 | 2004 | 305 |
Why?
|
Mice | 6 | 2000 | 623 |
Why?
|
Species Specificity | 2 | 2000 | 186 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2011 | 59 |
Why?
|
Tissue Distribution | 3 | 2002 | 124 |
Why?
|
Physicochemical Phenomena | 1 | 2009 | 26 |
Why?
|
Olfactory Bulb | 2 | 2004 | 15 |
Why?
|
Mesocricetus | 2 | 2005 | 17 |
Why?
|
Drug Delivery Systems | 1 | 2009 | 55 |
Why?
|
Mice, Inbred Strains | 2 | 2005 | 118 |
Why?
|
Time Factors | 2 | 2004 | 896 |
Why?
|
Cricetinae | 2 | 2005 | 130 |
Why?
|
Biological Transport | 2 | 2002 | 129 |
Why?
|
RNA, Messenger | 3 | 2000 | 394 |
Why?
|
Soot | 1 | 2006 | 3 |
Why?
|
Telemetry | 1 | 2007 | 19 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2006 | 31 |
Why?
|
Solubility | 1 | 2006 | 75 |
Why?
|
Chlorides | 1 | 2006 | 69 |
Why?
|
Oxidoreductases | 1 | 2006 | 41 |
Why?
|
No-Observed-Adverse-Effect Level | 1 | 2005 | 6 |
Why?
|
Peroxidase | 1 | 2005 | 27 |
Why?
|
Oxidation-Reduction | 1 | 2006 | 124 |
Why?
|
Organ Size | 1 | 2005 | 118 |
Why?
|
Veins | 1 | 2005 | 41 |
Why?
|
Sodium Chloride | 1 | 2005 | 77 |
Why?
|
Endpoint Determination | 1 | 2004 | 27 |
Why?
|
Body Weight | 1 | 2005 | 178 |
Why?
|
Heart Rate | 1 | 2007 | 138 |
Why?
|
Endothelin-2 | 1 | 2004 | 8 |
Why?
|
Radiation Pneumonitis | 1 | 2004 | 12 |
Why?
|
Leukocyte Count | 1 | 2004 | 94 |
Why?
|
Liposomes | 1 | 2004 | 38 |
Why?
|
Blotting, Western | 1 | 2006 | 275 |
Why?
|
Macrophage Activation | 1 | 2004 | 42 |
Why?
|
Deoxyguanosine | 1 | 2003 | 7 |
Why?
|
Orthomyxoviridae | 1 | 2004 | 34 |
Why?
|
DNA Adducts | 1 | 2003 | 12 |
Why?
|
Silicon Dioxide | 1 | 2004 | 27 |
Why?
|
Immunocompromised Host | 1 | 2004 | 70 |
Why?
|
Cell Count | 2 | 2000 | 163 |
Why?
|
Nerve Tissue Proteins | 1 | 2006 | 128 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2004 | 51 |
Why?
|
New York | 2 | 2004 | 422 |
Why?
|
Thrombosis | 1 | 2005 | 105 |
Why?
|
DNA Damage | 1 | 2003 | 66 |
Why?
|
RNA | 1 | 2006 | 126 |
Why?
|
Cell Proliferation | 1 | 2005 | 227 |
Why?
|
Electrocardiography | 1 | 2007 | 132 |
Why?
|
Analysis of Variance | 2 | 2000 | 339 |
Why?
|
Luminescent Measurements | 1 | 2000 | 35 |
Why?
|
Bronchoalveolar Lavage | 1 | 2000 | 24 |
Why?
|
Copper | 2 | 2010 | 36 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2000 | 69 |
Why?
|
Respiratory Burst | 1 | 2000 | 10 |
Why?
|
Pulmonary Emphysema | 1 | 2000 | 24 |
Why?
|
Metallothionein | 1 | 2000 | 23 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2000 | 83 |
Why?
|
Cells, Cultured | 2 | 2000 | 447 |
Why?
|
Mice, Inbred C57BL | 2 | 2000 | 318 |
Why?
|
DNA | 1 | 2003 | 262 |
Why?
|
Liver | 1 | 2002 | 248 |
Why?
|
Oxidative Stress | 1 | 2000 | 119 |
Why?
|
Humans | 3 | 2006 | 1856 |
Why?
|
Disease Models, Animal | 1 | 2000 | 349 |
Why?
|
Female | 4 | 2003 | 1643 |
Why?
|
Silver | 1 | 2011 | 8 |
Why?
|
NAD | 1 | 2011 | 41 |
Why?
|
Glucuronidase | 1 | 2010 | 26 |
Why?
|
Gold | 1 | 2010 | 17 |
Why?
|
Luciferases | 1 | 2010 | 70 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2006 | 13 |
Why?
|
Biological Markers | 1 | 2010 | 262 |
Why?
|
Glutamate-Cysteine Ligase | 1 | 2006 | 17 |
Why?
|
Random Allocation | 1 | 2006 | 160 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 257 |
Why?
|
Rose Bengal | 1 | 2005 | 3 |
Why?
|
Tissue Fixation | 1 | 2005 | 13 |
Why?
|
Polystyrenes | 1 | 2005 | 15 |
Why?
|
Ear, External | 1 | 2005 | 23 |
Why?
|
Amides | 1 | 2005 | 28 |
Why?
|
Infusions, Intravenous | 1 | 2005 | 87 |
Why?
|
Regional Blood Flow | 1 | 2005 | 105 |
Why?
|
Telencephalon | 1 | 2004 | 19 |
Why?
|
Motor Vehicles | 1 | 2004 | 3 |
Why?
|
Weather | 1 | 2004 | 11 |
Why?
|
Fluorescent Dyes | 1 | 2005 | 115 |
Why?
|
Cerebellum | 1 | 2004 | 59 |
Why?
|
Body Burden | 1 | 2003 | 24 |
Why?
|
Equipment Design | 1 | 2004 | 132 |
Why?
|
Recovery of Function | 1 | 2003 | 91 |
Why?
|
Mass Spectrometry | 1 | 2002 | 57 |
Why?
|
Monocytes | 1 | 2004 | 124 |
Why?
|
Drug Administration Schedule | 1 | 2003 | 191 |
Why?
|
Macrophages | 1 | 2004 | 148 |
Why?
|
Reproducibility of Results | 1 | 2005 | 391 |
Why?
|
Immunohistochemistry | 1 | 2005 | 355 |
Why?
|
Pilot Projects | 1 | 2002 | 264 |
Why?
|
Endothelium, Vascular | 1 | 2005 | 139 |
Why?
|
